Patent · US Expired

Inhibitors of factor Xa

US6399627B1 · kind B1 · utility

23Cited by
1References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 11, 2000
Grant dateJun 4, 2002
Priority date
Expiry dateFeb 11, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/10
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.